For the man whose PSA is rising, who has been advised to have a biopsy, or who has received frightening news about his prostate.

An elevated PSA does not automatically mean cancer.

PSA can rise for many reasons. Infection, inflammation, recent medical procedures, and other prostate conditions can affect PSA levels. Benign prostatic hyperplasia, often called BPH or an enlarged prostate, can contribute to urinary symptoms and PSA changes. Prostatitis — inflammation of the prostate — may also raise PSA. The National Cancer Institute notes that infection or inflammation of the prostate can raise PSA temporarily, and that doctors may recommend repeating the PSA test before moving to the next step.

That does not mean an elevated PSA should be ignored. It means it should be understood in context.

For many men, the most frightening word they can hear from a doctor is cancer. Whether cancer is merely suspected or has been confirmed through a biopsy, that word can change the room. It can make a man feel as though he has been pushed onto a conveyor belt — PSA, MRI, biopsy, diagnosis, treatment — without enough time to stop and ask what each step means.

If you have searched the internet for answers and come away more confused than when you started, you are not alone. Much of what appears online is either too shallow, too technical, too promotional, or too narrowly focused on the conventional treatment pathway. On the other hand, much of the scientific literature is difficult for a layperson to read without help.

There is valuable information available through PubMed, a free resource maintained by the National Library of Medicine that provides access to millions of citations and research abstracts from biomedical and life sciences literature. But PubMed is vast. It is written largely for doctors, scientists, and researchers, not for ordinary men and families trying to make sense of a frightening diagnosis.

That is part of why this site exists.

My goal is to help distill some of what I have found — from medical literature, books, physicians, researchers, patients, and survivors — into plain English. Not to tell you what to do. Not to replace your doctor. Not to give medical advice. But to help you ask better questions, understand competing and alternative viewpoints, and become a more informed participant in your own care.

One of the first things I discovered is this: in many prostate situations, you may have more time to stop and think than you first believe.

That does not mean delay is always safe. It does not mean every prostate cancer is slow-growing. It does not mean medical advice should be ignored. But it does mean that fear should not be the only voice in the room.

Doctors play an important role. They can order tests, interpret imaging, diagnose disease, perform procedures, prescribe medications, and explain conventional standard-of-care options. I am grateful for good doctors and good medicine.

But I do not believe the advice of a doctor should always be the end of the discussion.

Most physicians are trained primarily in the conventional medical model. Their recommendations are usually shaped by the standard of care, medical-school training, specialist guidelines, liability concerns, insurance reimbursement, institutional protocols, and the tools available within their specialty. That does not make their advice worthless. But it does mean their advice may not include every science-based question, emerging therapy, metabolic strategy, nutritional approach, supplement consideration, or off-label-drug discussion that a patient may want to understand.

There are areas of research that do not fit neatly into the standard medical visit. Some are preliminary. Some are controversial. Some are supported by stronger evidence than others. Some may turn out to be useful; others may not. But a patient facing a frightening diagnosis should not be discouraged from asking serious, evidence-based questions simply because those questions fall outside the usual treatment script.

This site exists to explore that additional perspective.

Not as medical advice.
Not as a substitute for a qualified physician.
Not as a promise of cure.
Not as an invitation to reject useful medical care.

But as a research journey — one that examines conventional recommendations, alternative and integrative approaches, metabolic theories, supplements, off-label-drug research, patient stories, published studies, risks, limitations, and unanswered questions.

I am not anti-doctor, and I am not anti-medicine. Good doctors matter. Good testing matters. Surgery, radiation, hormone therapy, chemotherapy, imaging, pathology, and conventional oncology all have a place in modern cancer care.

But I am also not persuaded that the conventional model has asked every important question or followed every promising trail. In cancer research, some ideas have been elevated while others have been marginalized. Some theories fit neatly within the standard medical model; others do not. Sometimes that is because the evidence is weak. But sometimes it may be because dogma, institutional habit, financial incentives, professional risk, or narrow training make it difficult for new or neglected ideas to receive a fair hearing.

One of the books that caused me to think more deeply about this was Tripping Over the Truth, which explores the history of cancer metabolism and raises serious questions about whether the dominant cancer-treatment model has overlooked important metabolic insights.

That does not mean every alternative theory is true. It does not mean every supplement, diet, metabolic strategy, or off-label-drug idea is safe or effective. But it does mean these questions deserve careful, honest, evidence-based examination rather than reflexive dismissal.

Prostate cancer is not one single disease with one single path. Some cases are low-risk and may be monitored through active surveillance. Others are aggressive and require prompt treatment. Recognized treatment approaches may include active surveillance, surgery, radiation therapy, hormone therapy, chemotherapy, targeted therapy, immunotherapy, or other treatments depending on the facts of the case.

That is why informed consent matters.

Informed consent should mean more than signing a form. It should mean understanding the decision, the evidence, the risks, the alternatives, and the consequences.

Before making life-altering decisions, a man should be able to ask:

What does my PSA actually mean?
Has it been repeated?
Could infection, inflammation, recent activity, or prostate enlargement be involved?
What does my MRI show?
What are the risks and benefits of biopsy?
What are the risks of waiting?
If cancer is found, what grade and stage is it?
Is active surveillance reasonable?
What are the risks of surgery, radiation, hormone therapy, or other treatments?
What happens if I choose one path and later regret it?
What questions should I ask before consenting?
What other science-based or alternative approaches warrant careful consideration?

Doctors provide expertise, training, testing, diagnosis, and treatment recommendations. But the patient is the one who lives with the consequences. As Dr. Nasha Winters emphasizes in The Metabolic Approach to Cancer, the patient is the one sitting in the treatment chair, not the doctor.

The doctor may recommend.

But the patient must decide.

And the patient is the one who lives with the result.

This site is for the man who wants to slow down, learn, ask, compare, pray, think, discuss, and decide with his eyes open.

Not passively.

Not fearfully.

But as an informed patient.